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OriginalBasicSciencePediatric Deceased Donation—A Report of the
Transplantation Society Meeting in Geneva
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Stuart C. Sweet, MD, PhD,12 Richard S. Trompeter, FRCP, FRCPCH,13 Farhat Moazam, MD, PhD,14
Michael A. Bos, MSoc,15 and Francis L. Delmonico, MD16
The Ethics Committee of The Transplantation Society convened a meeting on pediatric deceased donation of organs in Geneva,
Switzerland, on March 21 to 22, 2014. Thirty-four participants from Africa, Asia, the Middle East, Oceania, Europe, and North and
South America explored the practical and ethical issues pertaining to pediatric deceased donation and developed recommenda-
tions for policy and practice. Their expertisewas inclusive of pediatric intensive care, internal medicine, and surgery, nursing, ethics,
organ donation and procurement, psychology, law, and sociology. The report of the meeting advocates the routine provision of
opportunities for deceased donation by pediatric patients and conveys an international call for the development of evidence-
based resources needed to inform provision of best practice care in deceased donation for neonates and children.
(Transplantation 2015;99: 1403–1409)OVERVIEW OF THE MEETING
An international meeting was convened by the Ethics
Committee of The Transplantation Society in Geneva,
Switzerland, onMarch 21 and 22, 2014, to explore the prac-
tical and ethical issues pertaining to pediatric deceased dona-
tion of organs (hereafter, pediatric donation). There were
34 participants from Africa, Asia, the Middle East, Oceania,
Europe, and North and South America, with expertise in-
clusive of pediatric intensive care, internal medicine, and
surgery, nursing, ethics, organ donation and procurement,Received 1 July 2014. Revision requested 10 November 2014.
Accepted 21 December 2014.
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selected by a multidisciplinary steering committee, and rep-
resentation was sought from regional professional societies
of transplantation.
The intent of the meeting was to provide ethically in-
formed practical recommendations for health professionals
and policymakers seeking to establish or improve existing pe-
diatric organ donation programs globally, and to identify
neglected opportunities for research in this field. Four work
groups were electronically convened prior to the meeting, to
address the following topics that were subsequently presented
and reviewed in breakout and plenary sessions in Geneva:14 Center of Biomedical Ethics and Culture, SIUT, Karachi, Pakistan.
15 Ethics Committee, The Transplantation Society, Montreal, QC, Canada.
16 Massachusetts General Hospital, Harvard Medical School, Boston, MA.
The Transplantation Society Meeting in Geneva on Pediatric Deceased Donation
was funded by the Transplantation Society and an educational grant from Teva.
Teva had no role in the design and conduct of the meeting, nor in the preparation,
review, or approval of this manuscript.
The authors declare no conflicts of interest.
D.M. wrote the initial draft of this article, and was responsible for subsequent
revisions, with substantial assistance from T.N. F.L.D. participated in the design
and drafting of the article. T.N., M.S., K.B., J.B., F.D., J.R., M.S., R.S. also
assisted with revisions to the article. B.D.G. contributed writing and assisted with
important structural revisions. G.D., S.S., R.T., F.M., and M.B. contributed to the
writing and content to revisions of the article.
Correspondence: Dominique Martin, Level 4, 207 Bouverie Street, University of
Melbourne, 3010, Australia. (dominique.martin@unimelb.edu.au).
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0041-1337/15/9907-1403
DOI: 10.1097/TP.0000000000000758
www.transplantjournal.com 1403
ealth, Inc. All rights reserved.
TABLE 1.
List of pediatric donor meeting participants
Barbari Antoine Representative MESOT, Lebanon
Bennett Renee Representative ITNS, United States
Bos Michael Chair, TTS Ethics Committee, the
Netherlands
Bouësseau Marie-Charlotte WHO, Switzerland
Bramstedt Katrina Bond University, Australia
Brierley Joe Great Ormond Street Hospital for Sick
Children, United Kingdom
Danovitch Gabriel UCLA, United States
Delmonico Francis President, TTS, Canada
Dhawan Anil Representative ILTS, United Kingdom
Dobbels Fabienne University of Leuven (KU Leuven), Belgium
Domínguez -Gil Beatriz Representative ONT, Spain
Ha Jongwon Representative AST, South Korea
Harmon William Children's Hospital Boston, United States
Joseph Mathewa Christian Medical College Vellore, India
Langer Robert Semmelweis Institute, Hungary
Lewis Penney King's College London, United Kingdom
Martin Dominique The University of Melbourne, Australia
McCulloch Mignon University of Cape Town, South Africa
McDiarmid Suea UCLA, United States
Moazam Farhat Center for Biomedical Ethics and Culture,
SIUT, Pakistan
Myrick Craig Representative NATCO, United States
Nakagawa Thomas Wake Forest School of Medicine,
United States
Nino-Murcia Alejandro Representative STALYC, Colombia
Noël Luc WHO, Switzerland
O'Connell Philip President-Elect TTS, Australia
Rodrigue James Beth Israel Deaconess Medical Centre,
United States
Sarwal Minnie University of California San Francisco,
United States
Schotsmans Paula Representative ESOT, Belgium
Shapiro Ron Children's Hospital Pittsburgh, United States
Siebelink Marion University Medical Centre Groningen, the
Netherlands
Siminoff Laura Temple University, United States
Sweet Stuart Representative ISHLT, United States
Trompeter Richard Representative IPTA, United Kingdom
Weimar Willem Representative ELPAT, the Netherlands
a These individuals participated in preparatory work for the meeting but were unable to attend in
person.
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Unit (PICU)
• Ethical Challenges in End-of-Life Care
• Family Decision Making
• Allocation of Pediatric Donor Organs
A further plenary session occurred to discuss the issue of
death determination in children. In this report, we review
the common themes of discussion and key recommendations
that emerged from this meeting.
THE IMPORTANCE OF PEDIATRIC DONATION
Organizations, such as the American Academy of Pediat-
rics, encourage physician education and participation in pe-
diatric donation, collaboration with organ procurementCopyright © 2015 Wolters Kluwerorganizations, and advocate equity in donation and trans-
plantation.1 Nevertheless, pediatric donation remains a
neglected subject of research and public commentary interna-
tionally.2 This contributes to a lack of awareness among pol-
icy makers, health professionals, and the public regarding
opportunities to establish or improve donation programs.
Optimizing donation and utilization of pediatric organs
and the experience of donor families and professional staff
involved in their care are key components of efforts to meet
increasing needs for transplantation. Thousands of children
and adults benefit from transplants using deceased donor
organs annually.3 However, limitations inherent in size-
matching organs to pediatric recipients exacerbate difficul-
ties in providing transplants for children.More than 150 chil-
dren die annually while awaiting organ transplantation in
the United States and Europe.2,4,5 Although deaths may be
declining, more children are removed from waiting lists be-
cause their condition deteriorates, and they become ineligi-
ble for transplantation.4 In some countries, lack of pediatric
deceased donation programs means that children in need
of transplantation, especially hearts, lungs, and livers, will
die unless they are able to travel abroad and receive compas-
sionate access to foreign transplant programs.
Pediatric donation represents a small but invaluable por-
tion of the deceased donor pool, comprising roughly 6% of
deceased donors in the United States6 and 3% in Australia,7
the United Kingdom,8 Spain,9 and Eurotransplant countries.
Conversely, children comprise approximately 1.5% of the
waiting list for transplantation in the United States11 and in
Eurotransplant countries,10 2% in the United Kingdom,12
3% in Australia,13 and 6% in Spain.9 (We note there is inter-
national variation in definition of pediatric donors accord-
ing to age: in the United States and the United Kingdom,
pediatric donors are those in the category of 0 to 17 years;
in Australia and Spain, published data groups pediatric do-
nors from 0 to 14 years, and in Eurotransplant from 0 to
15 years.10 For the purpose of organ allocation, definition of
pediatric recipients according to age also varies between and
within countries and according to organ type.10)
Studies evaluating the potential of neonatal and pediatric
donation are scarce.14-18 Nevertheless, the proportion of
PICU deaths potentially suitable for organ donation in coun-
tries such as Spain and the Netherlands is estimated at ap-
proximately 11%.9,14 The falling rates of donation after
brain death and rising rates of donation after circulatory death
(DCD) in the United States3 and some Western European
countries9,14 indicate an evolving pattern of donor potential
in general terms, and in pediatrics in particular. The inci-
dence of brain death in the pediatric population is fortunately
declining as a result of general safety measures and advance-
ments in neurocritical care. This has been observed in a re-
cent study in Spain (from 25 pediatric brain death cases per
million population in 2000 to less than 10 in 2011).9DONATION IN END-OF-LIFE CARE
Withdrawal of life-sustaining medical therapies should
be viewed as a process, rather than an event. Opportunities
for donation are often lost during end-of-life care, especially
when withdrawal of medical therapies takes place without
early notification of “key donation persons” (KDPs) to allow
engagement with the family or health care team and to Health, Inc. All rights reserved.
© 2015 Wolters Kluwer Martin et al 1405enable timely evaluation of possible donors.18 Noting there
is considerable international variation in terminology and
role descriptions of professionals engaged in organ recovery
activities, the term “key donation person” is used through-
out this report to refer to an organ donation specialist or
equivalent: the professional with primary responsibility for
donation in a particular setting. The KDP should be included
in discussions about end-of-life care and donation with other
individuals responsible for provision of end-of-life care. An
institutional culture where end-of-life care is inclusive of
opportunities for donation supports early referral and pre-
serves the option of donation for patients and families.
Forensic cases involving the medical examiner or coroner
may also impair opportunities for donation when request
for donation is denied by these authorities.18 Early involve-
ment and education of the medical examiner or coroner is
essential to ensure evidence is not altered or lost during the
donation process.
Despite the well-recognized value of saving and improving
lives through organ transplantation, families and health care
professionals may perceive elements of the donation process
as ethically challenging during end-of-life care. These ethical
challenges can occur during patient management, and espe-
cially in the context of DCD.19,20 Unfounded parental hopes
of recovery and survival, and fears that cessation of futile in-
terventions may result in withdrawal of care for their child
may underpin reluctance to consider donation.19,21 Concerns
about harming potential donors or their families through dis-
cussion of donation, use of interventions to preserve dona-
tion opportunities, or recovery of organs after death is
declared may discourage health professionals from enabling
donation opportunities.20 These apparent conflicts between
the interests of a potential donor and their family and the
benefits anticipated from donation may result from inade-
quate communication between staff and family. Further-
more, lack of appropriate education about donation and
end-of-life care, and lack of experience among staff for whom
pediatric donation is usually a rare event can result in poor
understanding and implementation of donation protocols
and procedures, ultimately affecting the donation process.
When providing end-of-life care, the child's best interests
must be paramount, with due consideration of the principles
of beneficence (promoting welfare) and nonmaleficence (min-
imizing harm). Such interests include previously expressed
preferences of the child regarding donation when these are
known.22 The interests of children, like those of adults, should
be recognized as socially embedded, with consideration for the
interests of families where relevant. Potential harms to the in-
terests of the child and family may include prolongation of
the dying process, use of futile interventions, and delayed deci-
sion making that may preclude the option for donation.
Provision of optimal care at the end of life is an ethical duty
of health care professionals caring for dying patients. This en-
compasses a duty not to offer or implement futile interven-
tions and to withdraw interventions when they become futile.
Families should be assured that the cessation or withdrawal of
interventions when deemed futile does not mean withdrawal
of care for the child. End-of-life care must include the man-
agement of the child's symptoms, including pain and suffer-
ing, as well as provision of emotional and spiritual support
to the child and family.19,23 It should be an expectation that
parents and family are offered the option of being presentCopyright © 2015 Wolters Kluwer Hduring end-of-life care and during the determination of
death.19,23
SYSTEMATIC IDENTIFICATION AND ROUTINE
REFERRAL OF POTENTIAL DONORS
Organs transplanted from pediatric donors provide excel-
lent outcomes for many recipients, yet multiple factors con-
tribute to missed or neglected opportunities for pediatric
donation.3,14-18 Evidence available indicates that rates of do-
nor identification within PICUs vary considerably.14,18 In a
national study conducted in the Netherlands, rates ranged
from 60% to 95% across different PICUs.14 In a national
U.S. study, hospitals with a level 1 trauma program and/or a
pediatric critical care fellowship had higher donation rates.18
Early assessment and routine referral of possible donors to a
KDP representing the relevant organ procurement organiza-
tion or equivalent should help to prevent missed opportunities
for donation, as evidenced in adult donation programs.24,25
Early referral increases parental authorization of donation by
allowing greater time to consider this option.19,26
All patients facing end-of-life issues should be considered
possible donors, particularly those presenting with devastat-
ing brain injury. Assessment of donor potential should be
determined using established guidelines27-30 and coordinated
with a KDP, or an expert in the area of organ donation. The
use of clinical triggers or other methods to facilitate prompt
identification of all possible donors, in conjunction with a
policy of required referral, will help to improve performance
in the process of pediatric donation.24 Systematic audit of all
potential donors should occur to ensure accountability and re-
sponsibility for all providers involved in the donation process.25
DETERMINATION OF DEATH
Deceased donation is conditional upon professional confi-
dence and societal trust in the determination of death and
must be supported by a legislative framework.31 Public and
also professional discomfort or even distrust in the process
of determining death in children may undermine support
for deceased donation. Factors thatmay impair opportunities
for donation within the hospital setting include: parents' and
health professionals' lack of knowledge and understanding
of death determination20,26; poor communication, including
the diversity of terminology used to describe death; and var-
iations in practice for the determination of death.32-35
All processes for the determination of pediatric death,
whether through neurological or circulatory criteria, should
be governed by regional, national, or international guidelines
(e.g.,36-38). Global standardization of practice is desirable;
however, there may be variable local requirements for
the process of death determination—such as use of specific
diagnostic modalities and the timing of repeat evaluations.
Policies governing determination of death should identify
suitably qualified professionals to determine death and stipu-
late requirements for the documentation of death. Determi-
nation of death should occur in a timely manner, and the
process should be carefully explained to parents so there is
understanding and confidence in this determination.
ENGAGEMENT WITH FAMILIES
Parents and families are central to the process of pediatric
donation. All families should be provided the opportunity toealth, Inc. All rights reserved.
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possibility exists. The option of donation should routinely
be offered in the context of end-of-life care, with a personal-
ized approach to each case taking into account cultural, reli-
gious, and other aspects related to the child and family, and
the circumstances of death.19,26
Understanding factors that influence parental decisions
can increase consent rates for donation. Where decision-
making occurs, many parents choose to authorize dona-
tion.14,18 However, research in this area of pediatric donation
is limited.Available evidence about approaching parents for pe-
diatric donation reveals differences from adult authorization
from a spouse. Although approach for donation by a trained
KDP is strongly recommended for adults, evidence suggests
that authorization for pediatric donation increases when a
competent and trusted person from the healthcare team and
a KDP discuss donation opportunities.26 An appropriate re-
questor need not be a clinician, provided they have received
suitable training in this field. Preexisting positive attitudes to-
ward organ donation, exposure to information about dona-
tion, family consensus, sensitivity of the requestor, sufficient
time for decision making, and introduction of the topic of do-
nation by a trusted member of the child's health care team
are among the factors which positively influence consent for
pediatric donation from families.19,26 Approaching families
about pediatric donation should be plannedwith close collabo-
ration between the KDP and the critical care team. Donation is
a decision made by the family or surrogate, not the health care
team.Medical staff should be prepared to support parents who
may initiate conversations about donation.26,39
The experience, expertise, and attitudes of health profes-
sionals in the PICU—and in the emergency department
where dying children are more rarely situated23—play a crit-
ical role in facilitating family decision making about dona-
tion and improving the overall experience of families during
the death of their child. Effective and ongoing communica-
tion with parents must begin early in the process of caring
for a critically ill or injured child. Families should be well in-
formed by treating clinicians throughout their time in hospi-
tal, with regular, clear, consistent and sensitively conveyed
communication, so as to assist in understanding and accep-
tance of a less than favourable outcome or impending death,
futility of interventions where relevant, and the determina-
tion and declaration of death.19,23,26
Donation discussions should assess and directly address
concerns and barriers to donation, including consideration
of the preferences of the child when known.22 Parents of po-
tential pediatric donors should be informed of the possible al-
location of pediatric organs to adult recipients, with reasons
for such allocation explained and the overall benefits to chil-
dren in need of transplantation detailed.3 Health care profes-
sionals providing end-of-life care should understand that
allowing families to pursue donation opportunities may po-
tentially provide solace as parents face the tragic loss of a
child. Careful consideration of donation opportunities may
minimize the risk of later regret from parents who decline
donation.19,26MANAGEMENT OF DONORS
Where possible, pediatric donors are best managed collab-
orating with KDP in a pediatric facility by pediatric criticalCopyright © 2015 Wolters Kluwercare specialists who understand the unique needs of children
and their families.18,40 Management of the potential donor
should be viewed as a continuum of care. This includes fam-
ily support throughout the donation process and appropriate
comfort measures for potential DCD donors. Continuation
of medical management after determination of death if dona-
tion is planned is essential to avoid loss of transplantable or-
gans. Medical care after death should be directed toward
sustaining organ viability. Specific protocols can preserve op-
portunities for donation and assist in standardizing donor
management. Use of donor management goals increases
available organs for transplantation.40-42 Protocols and
goals should be clearly established using existing national
or international resources and guidelines and complemented
by educational and training programs for relevant staff.
When implemented, consent rates for donation and the num-
ber of organs recovered for transplantation increase.43
Parental requests (e.g., regarding integration of cultural or
religious rituals with organ recovery process) should be hon-
ored where possible, and parents should be allowed to be
with their child until the time of organ recovery. Organ recov-
ery should be coordinated with surgical recovery teams and
operating room staff who participate in the continuum of
care. Parental support is essential during and after organ re-
covery and support should also be available for medical staff
after the emotionally taxing event of the death of a child. Do-
nation may comfort not only families, but also the medical
team,19,44 and donation outcomes should be shared with
the family and staff.ORGAN ALLOCATION
Allocation of pediatric donor organs is complicated by sev-
eral factors. Size matching considerations, organ-specific
issues, use of various prioritization schemes to optimize utili-
zation of pediatric donor organs, and access to transplanta-
tion for pediatric recipients.45-50 Allocation decisions may
influence public support and parental consent for pediatric
donation.19,26,49 Accordingly, allocation systems should
strive for transparency, so as to avoid for example parental
disappointment where organs are unexpectedly allocated to
adults, and ensure outcomes of allocation policies meet
their underlying goals. Allocation systems, including those
prioritizing pediatric recipients, should be carefully evalu-
ated with respect to their impact on pediatric access to or-
gan transplantation and optimal utilization of pediatric
donor organs.1,45,49
Use of neonatal and smaller pediatric donor organs is in-
creasing.2 Opportunities for transplantation of neonatal
and pediatric DCD organs into adult or pediatric recipients as
clinically appropriate should be maximized. Barriers to the re-
covery or use of neonatal and pediatric donor organs15,16 and
transplantation to pediatric recipients (e.g., concerns about ad-
herence, or lack of suitable recipients within national transplant
programs) undermine the goals of allocation policies and
should be addressed where possible. International collabora-
tion and use of organ sharing agreements may increase the uti-
lization of pediatric organs for transplantation by potentially
reducing discard of organs due to the lack of suitable local re-
cipients.48Ongoing research evaluating the use of vascularized
composite grafts and downsizing of adult deceased donor or-
gans for pediatric recipients should also continue. Allocation Health, Inc. All rights reserved.
TABLE 2.
Core recommendations of the expert working groups
Priority interventions
1. Promote public and professional awareness of pediatric deceased donation
• Pediatric specific data to be henceforth included in the Global Observatory on Organ Donation and Transplantation,52 to provide a comprehensive account of
activities internationally.
2. Improve public and professional understanding and support for donation through education
• Organizations responsible for the public education and promotion of donation are urged to develop and include information specific to pediatric donation;
• The media should be encouraged and assisted to report accurately and sensitively on deceased donation and related events to address myths
and misperceptions.
• Professionals responsible for managing critically ill children should routinely receive training in provision of end-of-life care and organ donation (including DCD),
as well as death determination;
• Healthcare teams and the KDP or organ recovery specialist should work together to increase chances of successful donation and recovery of pediatric organs;
• Health professionals from all specialties and disciplines (e.g. nurses, physicians, physician assistants and allied health workers including neonatology, palliative
care, anaesthesia, emergency medicine) who may be involved with care of potential or actual donors should be encouraged and enabled to access donation
education. Additionally, medical examiners and coroners should receive education about donation and work with healthcare teams to preserve the option of
donation;
• The Transplantation Society and other professional organizations should support educational and training opportunities at national and international professional
meetings;
• National and international professional organizations should assist in development and promotion of educational resources to meet local needs.
3. Expand research in pediatric donation
• Clinical, health policy and social science researchers should be encouraged and supported to undertake
○ cross-cultural research investigating attitudes of healthcare providers toward pediatric donation and potential barriers to their participation in donation
opportunities, and factors influencing family decision-making in pediatric donation;
○ evaluation of the potential for pediatric donation in the context of different health systems, and of factors impeding or facilitating opportunities to establish
donation programs;
• For established programs, ongoing evaluation of donation processes, policies and guidelines, including those governing allocation of recovered organs should
be performed and outcomes published.
4. Improve access to and implementation of policies and protocols
• Health authorities should strive to develop systems enabling potential pediatric donors to be cared for in pediatric institutions by individuals trained in the unique
needs of children and their families;
• Pediatric protocols should be routinely used where possible to standardize pediatric donation and management practices. Health authorities, professional
organizations, and healthcare institutions providing care for pediatric patients should collaborate and promptly establish plans for development, introduction
and implementation of standardized, best practice guidelines that can be adapted by local health systems. These should include guidelines for:
○ recognition of potential donors;
○ timely and accurate determination of death;
○ provision of care to potential donors and their families;
○ optimal management of the donor;
○ recovery, allocation, and transplantation of donor organs;
• All policies pertaining to pediatric donation and transplantation should be consistent with the WHO Guiding Principles on Human Cell, Tissue and Organ
Transplantation31 and the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.53
© 2015 Wolters Kluwer Martin et al 1407policies should be developed and appropriately revised as
these practices evolve (e.g.,49,51).
CORE RECOMMENDATIONS
The lack of research evaluating the international scope,
quality, and impact of policy and strategic interventions in
the field of pediatric donation provides a limited evidence
base for recommendations for practice. The consensus of
the expert working groups is that increased awareness, edu-
cation, and development and use of guidelines are require-
ments for best practice in pediatric donation. Furthermore,
research evaluating clinical practices and outcomes there-
of, education interventions, and implementation of policy
and guidelines will inform development of more specific
evidence-based guidelines and recommendations for prac-
tice in the future. Table 2 summarizes the core recommen-
dations for immediate intervention by governments, healthCopyright © 2015 Wolters Kluwer Hauthorities, institutions and professional organizations seek-
ing to improve pediatric donation. Although this meeting
was concerned with pediatric donation of solid organs, we
note that many of these recommendations are also applicable
to donation of tissue for transplantation.CONCLUSIONS
This report of the Transplantation Society Meeting on Pe-
diatric DeceasedDonation advocates the routine provision of
opportunities for deceased donation by pediatric patients.
Recommendations based on available evidence, expert opin-
ion, and consensus highlight the need for multidisciplinary
research and dedicated training and education in the field
of pediatric deceased donation among the public and health
care professionals to preserve and provide the opportunity
for donation where possible for children and their families.ealth, Inc. All rights reserved.
1408 Transplantation ■ July 2015 ■ Volume 99 ■ Number 7 www.transplantjournal.comThe importance of providing expert holistic care for chil-
dren and their families throughout the end of life, including
donation where relevant, consistent with ethically informed
evidence-based and consensus-based guidelines and policies
is noted. In particular, the need for consistency and confi-
dence in the determination of death through standardized
practice in accordance with regional, national, and interna-
tional guidelines is noted. TheMeeting thus conveys an inter-
national call for more clinical, social sciences and health
policy research in order to develop and evaluate evidence-
based resources needed to inform provision of best practice
care in deceased donation for neonates and children.
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